96554 ⎘
Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
FARNESOID X RECEPTOR MODULATORS
#2ORALLY ACTIVE LEUKEMIA INHIBITORY FACTOR (LIF) ANTAGONISTS FOR THE TREATMENT OF CANCER
#3INHIBITORS OF GLUCOCORTICOID RECEPTOR
#4INHIBITORS OF GLUCOCORTICOID RECEPTOR
#5Farnesoid X receptor modulators
#6Methods for onapristone synthesis dehydration and deprotection
#7Inhibitors of glucocorticoid receptor
#8INHIBITORS OF GLUCOCORTICOID RECEPTOR
#9Inhibitors of glucocorticoid receptor
#10AMORPHOUS ONAPRISTONE COMPOSITIONS AND METHODS OF MAKING THE SAME
#11Inhibitors of glucocorticoid receptor
#12Inhibitors of glucocorticoid receptor
#13Inhibitors of glucocorticoid receptor
#14Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents
#15Compositions and Methods for Non-Toxic Delivery of Antiprogestins
#16METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTION
#1717-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
#18Farnesoid X receptor modulators
#19Methods of making onapristone intermediates
#20Process for the production of 21-methoxy-11-beta-phenyl-19-nor-pregna-4,9-diene-3,20-dione derivatives
#21Industrial process for the synthesis of ulipristal acetate and its 4′-acetyl analogue
#22Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents
#2317-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
#24NOVEL PROCESS AND INTERMEDIATE FOR PREPARATION OF ULIPRISTAL
#25Crystalline polymorphic form of ulipristal acetate
#26Crystalline polymorphic form of ulipristal acetate
#27Method for preparing ulipristal acetate and key intermediate thereof
#28Onapristone polymorphic forms and methods of use
#29STRUCTURAL MODIFICATION OF 19-NORPROGESTERONE I: 17-ALPHA-SUBSTITUTED-11-BETA-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS NEW ANTIPROGESTATIONAL AGENTS
#304-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)
#31Progesterone receptor antagonists
#32COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS
#33Progesterone receptor antagonists
#3417-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
#3517-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases
#3617-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases
#3717-HYDROXY-17-PENTAFLUOROETHYL-ESTRA-4,9(10)-DIEN-11-ARYL DERIVATIVES, METHOD OF PRODUCTION THEREOF AND USE THEREOF FOR THE TREATMENT OF DISEASES
#38Crystal form of an organic compound and process for the preparation thereof
#3917-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
#40Crystalline form of antiprogestin CDB-4124
#41Progesterone antagonists
#42Industrial method for the synthesis of 17-acetoxy-11β[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
#4321-substituted progesterone derivatives as new antiprogestational agents
#44Industrial process for the synthesis of 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process
#45Crystalline form of the compound A-348441
#4611β-benzaldoxime derivatives of D-homooestra-4,9-dien-3-ones
#4721-substituted progesterone derivatives as new antiprogestational agents
#48Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
#4921-substituted progesterone derivatives as new antiprogestational agents
#50Antigestagenically active steroids with a fluorinated 17α-alkyl chain
#51Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy